What's Hot

    These have been the one shares that rose amid the inventory market’s wipeout Thursday | Invesloan.com

    November 19, 2026

    Protesters chant ‘Charlie Kirk deserved to die’ at UW occasion | Invesloan.com

    November 19, 2026

    A Former Oxford Researcher Says AI Could Help Us Live 1,400 Years | Invesloan.com

    November 19, 2026
    Facebook Twitter Instagram
    Finance Pro
    Facebook Twitter Instagram
    invesloan.cominvesloan.com
    Subscribe for Alerts
    • Home
    • News
    • Politics
    • Money
    • Personal Finance
    • Business
    • Economy
    • Investing
    • Markets
      • Stocks
      • Futures & Commodities
      • Crypto
      • Forex
    • Technology
    invesloan.cominvesloan.com
    Home » An AstraZeneca, Bristol Myers Squibb merger might create a cancer-drug large, however analysts name it ‘odd’ | Invesloan.com
    News

    An AstraZeneca, Bristol Myers Squibb merger might create a cancer-drug large, however analysts name it ‘odd’ | Invesloan.com

    August 3, 2026
    Share
    Facebook Twitter LinkedIn Pinterest Email


    AstraZeneca shares were slumping while Bristol-Myers Squibb’s stock was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Keep Reading

    These have been the one shares that rose amid the inventory market’s wipeout Thursday | Invesloan.com

    After Anthropic’s ‘bittersweet’ IPO, right here’s what lies forward | Invesloan.com

    TPG, Corpay to take BILL personal in $6B acquisition (BILL:NYSE) | Invesloan.com

    We’re in our 50s and afraid of a market crash. Should we put $400,000 of our $1 million retirement financial savings into an annuity? | Invesloan.com

    Why Micron, Broadcom and different AI shares gave up their good points Thursday | Invesloan.com

    Maximus forecasts $700M-$800M fiscal 2027 free money movement whereas integrating Agile Defense | Invesloan.com

    Biohaven inventory rises on most cancers remedy information (BHVN:NYSE) | Invesloan.com

    ‘Rockets are hard’ — but this analyst thinks AST SpaceMobile’s inventory is able to rebound | Invesloan.com

    U.S. equities commerce decrease on Anthropic’s debut | Invesloan.com

    LATEST NEWS

    These have been the one shares that rose amid the inventory market’s wipeout Thursday | Invesloan.com

    November 19, 2026

    Protesters chant ‘Charlie Kirk deserved to die’ at UW occasion | Invesloan.com

    November 19, 2026

    A Former Oxford Researcher Says AI Could Help Us Live 1,400 Years | Invesloan.com

    November 19, 2026

    After Anthropic’s ‘bittersweet’ IPO, right here’s what lies forward | Invesloan.com

    November 19, 2026
    POPULAR

    China’s first passenger jet completes maiden commercial flight

    May 28, 2023

    Numbers taking US accountancy exams drop to lowest level in 17 years

    May 29, 2023

    Toyota chair faces removal vote over governance issues

    May 29, 2023
    Advertisement
    Load WordPress Sites in as fast as 37ms!
    Facebook Twitter Pinterest WhatsApp Instagram
    © 2007-2023 Invesloan.com All Rights Reserved.
    • Privacy
    • Terms
    • Press Release
    • Advertise
    • Contact

    Type above and press Enter to search. Press Esc to cancel.

    invesloan.com
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}